Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Initial Therapy for Mantle Cell Lymphoma with Abbreviated R-CHOP Followed By Y-90-Ibritumomab Tiuxetan: Ten Year Follow-up of the Phase 2 ECOG-ACRIN Study E1499 Smith, M. R., Li, H., Hong, F., Gordon, L. I., Gascoyne, R. D., Paietta, E., Advani, R. H., Forrero-Torres, A., Horning, S. J., Kahl, B. S. AMER SOC HEMATOLOGY. 2015
View details for Web of Science ID 000368020102214